Načítá se...
Acute myeloid leukemia: advancing clinical trials and promising therapeutics
Recent progress in understanding the biology of acute myeloid leukemia (AML) and the identification of targetable driver mutations, leukemia specific antigens and signal transduction pathways has ushered in a new era of therapy. In many circumstances the response rates with such targeted or antibody...
Uloženo v:
| Vydáno v: | Expert Rev Hematol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5006674/ https://ncbi.nlm.nih.gov/pubmed/26910051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17474086.2016.1158096 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|